ILMN |
Illumina, Inc. |
24.10B |
5.79% |
|
|
|
|
|
151.28 |
-1.44% |
47.49% |
35.58% |
---|
ALNY |
Alnylam Pharmaceuticals, Inc. |
34.33B |
5.42% |
|
|
|
|
|
266.18 |
-1.40% |
41.83% |
26.61% |
---|
UTHR |
United Therapeutics Corporation |
16.85B |
5.33% |
|
|
|
|
|
377.36 |
0.15% |
29.39% |
51.67% |
---|
AMGN |
Amgen Inc. |
170.52B |
5.17% |
|
|
|
|
|
317.24 |
0.10% |
45.06% |
86.46% |
---|
BIIB |
Biogen Inc. |
25.45B |
4.77% |
|
|
|
|
|
174.69 |
0.67% |
27.57% |
32.18% |
---|
REGN |
Regeneron Pharmaceuticals, Inc. |
89.00B |
4.14% |
|
|
|
|
|
820.87 |
-0.96% |
33.62% |
65.26% |
---|
BMRN |
BioMarin Pharmaceutical Inc. |
12.49B |
4.11% |
|
|
|
|
|
65.54 |
-0.71% |
31.35% |
26.04% |
---|
NBIX |
Neurocrine Biosciences, Inc. |
12.07B |
4.06% |
|
|
|
|
|
119.23 |
-1.08% |
25.06% |
21.61% |
---|
XNCR |
Xencor, Inc. |
1.48B |
3.59% |
|
|
|
|
|
21.18 |
-1.58% |
60.09% |
56.93% |
---|
MNKD |
MannKind Corporation |
1.96B |
3.54% |
|
|
|
|
|
7.12 |
0.35% |
127.78% |
7.94% |
---|
PTGX |
Protagonist Therapeutics, Inc. |
2.68B |
3.26% |
|
|
|
|
|
45.55 |
-2.59% |
57.12% |
60.56% |
---|
EXEL |
Exelixis, Inc. |
9.81B |
3.15% |
|
|
|
|
|
34.36 |
0.19% |
22.92% |
-11.16% |
---|
CPRX |
Catalyst Pharmaceuticals, Inc. |
2.56B |
3.05% |
|
|
|
|
|
21.59 |
-0.74% |
51.23% |
39.87% |
---|
VCYT |
Veracyte, Inc. |
2.69B |
3.00% |
|
|
|
|
|
35.00 |
0.06% |
94.64% |
47.95% |
---|
TGTX |
TG Therapeutics, Inc. |
3.75B |
2.94% |
|
|
|
|
|
24.19 |
-0.70% |
37.06% |
29.15% |
---|
INCY |
Incyte Corporation |
14.66B |
2.89% |
|
|
|
|
|
76.09 |
0.45% |
31.11% |
51.34% |
---|
NTRA |
Natera, Inc. |
15.21B |
2.85% |
|
|
|
|
|
122.99 |
-0.36% |
63.69% |
46.86% |
---|
TECH |
Bio-Techne Corporation |
12.08B |
2.81% |
|
|
|
|
|
76.14 |
0.32% |
36.03% |
26.96% |
---|
BCRX |
BioCryst Pharmaceuticals, Inc. |
1.47B |
2.81% |
|
|
|
|
|
7.11 |
-3.33% |
55.49% |
19.57% |
---|
RGEN |
Repligen Corporation |
7.90B |
2.70% |
|
|
|
|
|
141.05 |
1.09% |
69.91% |
93.42% |
---|
COLL |
Collegium Pharmaceutical, Inc. |
1.06B |
2.67% |
|
|
|
|
|
32.94 |
0.67% |
105.24% |
96.47% |
---|
ACAD |
ACADIA Pharmaceuticals Inc. |
2.40B |
2.65% |
|
|
|
|
|
14.44 |
-1.23% |
62.17% |
48.91% |
---|
QGEN |
Qiagen N.V. |
9.68B |
2.63% |
|
|
|
|
|
43.64 |
-0.03% |
40.53% |
74.41% |
---|
BPMC |
Blueprint Medicines Corporation |
5.87B |
2.58% |
|
|
|
|
|
92.41 |
0.58% |
51.43% |
23.01% |
---|
NVAX |
Novavax, Inc. |
1.47B |
2.54% |
|
|
|
|
|
9.20 |
0.88% |
96.11% |
43.89% |
---|
OPK |
OPKO Health, Inc. |
1.01B |
2.51% |
|
|
|
|
|
1.4484 |
-2.14% |
98.16% |
32.27% |
---|
VCEL |
Vericel Corporation |
2.18B |
2.38% |
|
|
|
|
|
44.42 |
0.11% |
59.77% |
59.05% |
---|
MYGN |
Myriad Genetics, Inc. |
1.59B |
2.28% |
|
|
|
|
|
17.55 |
-1.57% |
71.52% |
127.73% |
---|
HALO |
Halozyme Therapeutics, Inc. |
7.34B |
2.27% |
|
|
|
|
|
57.67 |
-1.37% |
37.79% |
22.67% |
---|
CDNA |
CareDx, Inc |
1.19B |
2.05% |
|
|
|
|
|
22.60 |
-1.46% |
103.53% |
47.81% |
---|
AGPXX |
Invesco Government & Agency Portfolio |
|
0.05% |
|
|
|
|
|
|
|
|
|
---|